CD36 is important for adipocyte recruitment and affects lipolysis

Obesity

Volumn 21, Issue 10, 2013, Pages 2037-2045

  Vroegrijk, Irene O C M ^a   Van Klinken, Jan Bert ^a   Van Diepen, Janna A ^a   Van Den Berg, Sjoerd A A ^a   Febbraio, Maria ^b   Steinbusch, Laura K M ^c,f   Glatz, Jan F C ^c   Havekes, Louis M ^a,d   Voshol, Peter J ^a,e   Rensen, Patrick C N ^a   Van Dijk, Ko Willems ^a   Van Harmelen, Vanessa ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d TNO   (Netherlands)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN;

ADIPOCYTE; ADIPOCYTE RECRUITMENT; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL FUNCTION; CELL MATURATION; CELL SIZE; CONTROLLED STUDY; GONADAL ADIPOSE TISSUE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; LIPID STORAGE; LIPOLYSIS; MALE; MOUSE; NONHUMAN; PROADIPOCYTE; SUBCUTANEOUS FAT;

MUS;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD36; CELL DIFFERENTIATION; CELL SIZE; DIET, HIGH-FAT; FATTY ACIDS; INSULIN; LIPOLYSIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; TRIGLYCERIDES;

EID: 84885385322     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20354     Document Type: Article

References (33)

1. Defronzo RA,. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010; 53 (7): 1270-1287.
2. Abumrad N, Coburn C, Ibrahimi A,. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim Biophys Acta 1999; 1441 (1): 4-13.
3. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA,. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993; 268 (24): 17665-17668.
4. Silverstein RL, Febbraio M,. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2009; 2 (72): re3.
5. Coburn CT, Knapp FF, Jr., Febbraio M, Beets AL, Silverstein RL, Abumrad NA,. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 2000; 275 (42): 32523-32529.
6. Hajri T, Hall AM, Jensen DR, et al. CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue. Diabetes 2007; 56 (7): 1872-1880.
7. Koonen DP, Sung MM, Kao CK, et al. Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistance. Diabetes 2010; 59 (6): 1366-1375.
8. Steinbusch LK, Luiken JJ, Vlasblom R, et al. Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am J Physiol Endocrinol Metab. 2011; 301 (4): E618-E627.
9. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999; 274 (27): 19055-19062.
10. Rensen PC, Van Berkel TJ,. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem 1996; 271 (25): 14791-14799.
11. Jong MC, Rensen PC, Dahlmans VE, van der Boom H, Van Berkel TJ, Havekes LM,. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. J Lipid Res 2001; 42 (10): 1578-1585.
12. Rensen PC, Herijgers N, Netscher MH, Meskers SC, van EM, Van Berkel TJ,. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J Lipid Res 1997; 38 (6): 1070-1084.
13. Bligh EG, Dyer WJ,. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37 (8): 911-917.
14. Jo J, Gavrilova O, Pack S, et al. Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol 2009; 5 (3): e1000324.
15. Clark AM, Sousa KM, Jennings C, MacDougald OA, Kennedy RT,. Continuous-flow enzyme assay on a microfluidic chip for monitoring glycerol secretion from cultured adipocytes. Anal Chem 2009; 81 (6): 2350-2356.
16. Voshol PJ, Jong MC, Dahlmans VE, et al. In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 2001; 50 (11): 2585-2590.
17. Macotela Y, Boucher J, Tran TT, Kahn CR,. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 2009; 58 (4): 803-812.
18. Stubbins RE, Najjar K, Holcomb VB, Hong J, Nunez NP,. Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes Metab 2012; 14 (1): 58-66.
19. Cai L, Wang Z, Ji A, Meyer JM, van der Westhuyzen DR,. Scavenger receptor CD36 expression contributes to adipose tissue inflammation and cell death in diet-induced obesity. PLoS One 2012; 7 (5): e36785.
20. Collins JM, Neville MJ, Pinnick KE, et al. De novo lipogenesis in the differentiating human adipocyte can provide all fatty acids necessary for maturation. J Lipid Res 2011; 52 (9): 1683-1692.
21. Christiaens V, Van Hul M, Lijnen HR, Scroyen I,. CD36 promotes adipocyte differentiation and adipogenesis. Biochim Biophys Acta 2012;1820:949-956.
22. Laurencikiene J, Skurk T, Kulyte A, et al. Regulation of lipolysis in small and large fat cells of the same subject. J Clin Endocrinol Metab 2011; 96 (12): E2045-E2049.
23. Kalderon B, Azazmeh N, Azulay N, Vissler N, Valitsky M, Bar-Tana J,. Suppression of adipose lipolysis by long-chain fatty Acid analogs. J Lipid Res 2012;53:868-878.
24. Hertzel AV, Smith LA, Berg AH, et al. Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am J Physiol Endocrinol Metab 2006; 290 (5): E814-E823.
25. Zhou D, Samovski D, Okunade AL, Stahl PD, Abumrad NA, Su X,. CD36 level and trafficking are determinants of lipolysis in adipocytes. FASEB J 2012; 26 (11): 4733-4742.
26. Arner E, Westermark PO, Spalding KL, et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010; 59 (1): 105-109.
27. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE,. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000; 43 (12): 1498-1506.
28. Lundgren M, Svensson M, Lindmark S, Renstrom F, Ruge T, Eriksson JW,. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 2007; 50 (3): 625-633.
29. Kennedy DJ, Kuchibhotla S, Westfall KM, Silverstein RL, Morton RE, Febbraio M,. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc Res 2011; 89 (3): 604-613.
30. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87 (7): 3023-3028.
31. Tiikkainen M, Tamminen M, Hakkinen AM, et al. Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 2002; 10 (9): 859-867.
32. Coomans CP, Biermasz NR, Geerling JJ, et al. Stimulatory effect of insulin on glucose uptake by muscle involves the central nervous system in insulin-sensitive mice. Diabetes 2011; 60 (12): 3132-3140.
33. Bays HE, Gonzalez-Campoy JM, Henry RR, et al. Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract 2008; 62 (10): 1474-1483.